How can buyers maximize the value of their acquisitions?
Michael Abrams, Numerof & Associates
Advertisement
Managing partner at Numerof & Associates.
Articles by Michael Abrams, Numerof & Associates
A lack of access could shut out patients in need of maintenance drugs for complex conditions.
A new, market-driven model of drug development and commercialization is appearing*
Advertisement
Latest Updated Articles
- Bringing value to healthcare: practical steps for getting to a market-based model
Published: March 9th 2016 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Why Continuous Vendor Oversight Is Key to Healthcare Data Security
2
Optimizing Your CGT Commercial Distribution Strategy: Four Priorities for a Successful Launch
3
One Connection, Endless Impact: Improving Patient Medication Access
4
Lilly Reveals Plan for New $3 Billion Manufacturing Facility in the Netherlands
5
